MAREA THERAPEUTICS: ANNOUNCES MAR001 REDUCES TRIGLYCERIDES WITHOUT WORSENING GLYCEMIC CONTROL IN PHASE 2B TYDAL-TIMI 78 TRIAL

Reuters · 2d ago

Please log in to view news